Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation Cohort.

Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation Cohort.

There are no data comparing the response to PI/r-based regimens in people presenting for care with low CD4 counts or AIDS (LC).To compare the response to LPV/r-, DRV/r- or ATV/r-based cART regimens in LC initiating cART from ART-naive.We included people enrolled in Icona with either CD4 counts ≤350...

Full description

Bibliographic Details
Main Authors: Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Franco Maggiolo, Giuliano Rizzardini, Paolo Emilio Manconi, Nicola Gianotti, Tiziana Quirino, Carmela Pinnetti, Stefano Rusconi, Andrea De Luca, Andrea Antinori, Icona Foundation Study cohort
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4922579?pdf=render

Internet

http://europepmc.org/articles/PMC4922579?pdf=render

Similar Items